Bulletin
Investor Alert

Jan. 21, 2022, 10:23 a.m. EST

IBM sheds Watson Health assets as it works to refocus its business

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    International Business Machines Corp. (IBM)
  • X
    Dow Jones Industrial Average (DJIA)

or Cancel Already have a watchlist? Log In

By Emily Bary

International Business Machines Corp. will sell assets from its Watson Health business to an investment firm as it continues to refocus its business.

IBM /zigman2/quotes/203856914/composite IBM +2.09% and Francisco Partners announced Friday that the investment firm will purchase “extensive and diverse data sets and products” from IBM that are currently part of the Watson Health business. The companies expect the deal to close in the second quarter. Financial terms were not disclosed.

IBM shares are off 0.2% in Friday trading. They have gained 6.5% over the past three months, while the Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA +1.98% has lost 3.0%.

The Wall Street Journal reported in early 2021 that IBM was considering a sale of the Watson Health business , and a report from Axios earlier this year indicated that the company was still interested in a deal .

Subscribe:  Want intel on all the news moving markets? Sign up for our daily Need to Know newsletter.

The transaction isn’t surprising, according to UBS analyst David Vogt, since key IBM executive and Watson proponent John Kelly retired from the company at the end of 2020.

“Moreover, we believe the market has been anticipating ongoing small changes to IBM’s portfolio to divest businesses that do not neatly fit into its three new business segments,” he wrote in a note to clients.

IBM sees the deal as a way to become “even more focused on our platform-based hybrid cloud and AI strategy,” Tom Rosamilia, its senior vice president for IBM Software, said in a release.

Though the companies didn’t disclose financial terms of the arrangement, Vogt doubted that it would materially impact IBM’s financials “given the likely limited success of this unit the past several years.”

He noted that, with Watson Health, IBM completed numerous acquisitions as it sought to disrupt the healthcare field by combining areas like patient records, medical literature, and medical imaging, and applying data analytics to the process.

IBM is due to report fourth-quarter earnings on Jan. 24.

/zigman2/quotes/203856914/composite
US : U.S.: NYSE
$ 131.17
+2.69 +2.09%
Volume: 3.59M
May 23, 2022 4:00p
P/E Ratio
21.53
Dividend Yield
5.03%
Market Cap
$115.56 billion
Rev. per Employee
$218,641
loading...
/zigman2/quotes/210598065/realtime
US : Dow Jones Global
31,880.24
+618.34 +1.98%
Volume: 405.83M
May 23, 2022 5:43p
loading...

This Story has 0 Comments
Be the first to comment
More News In
Industries

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.